A study reported that frequencies of anti-topo I (+) CD27+CD19+ B cells were significantly expanded in anti-topo I autoAb-positive SSc patients compared to healthy controls and anti-CENP autoAb-positive SSc patients (32). Here, CD19 is linked to systemic sclerosis.